CG Structure · 2025
In this section20 topics
- Board Composition8 items
- Board of Directors1 item
- Board Meetings & Remuneration5 items
- Balance of Power Between the Board and Management3 items
- Board Roles, Duties and Charter2 items
- Other Board Governance Matters1 item
- Subcommittees — Overview1 item
- Audit Committee6 items
- Executive Committee6 items
- Other Subcommittees1 item
- Executives2 items
- Executive Remuneration5 items
- Remuneration Policy3 items
- Employees3 items
- Provident Fund5 items
- Policy for Employees Not in the Provident Fund6 items
- Auditors and Audit Fees2 items
- Company Secretary and Other Assigned Persons6 items
- Investor Relations Contact2 items
- Representatives in Thailand (Foreign Companies)1 item
Board Composition
Total Number of Directors
12
Male Directors
9
Female Directors
3
Independent Directors
6
Non-executive Directors
7
Non-executive Directors Who Are Not Independent
1
Executive Directors
5
Total Board Meetings Held
12
Board of Directors
Directors
| Title | First Name | Last Name | Gender | Year of Birth | Nationality | Resident in Thailand? | Position | Executive or Non-executive | Independent Director? | Director Type | Appointment Date | Authorised to Sign? | Related to Another Director or Executive? | Any Legal Violation in the Past 5 Years? | Highest Education | Field of Study | Field of Study — Please Specify | Skills & Expertise | Director Training | Attended Director Training? | Director Accreditation Program (DAP)? | Director Certification Program (DCP)? | Board Meetings Held | Board Meetings Attended | AGMs Held | AGMs Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration | Shares Held | Shareholding (%) | Shares Held by Related Persons (s.59) | Shareholding by Related Persons (s.59, %) | Indirect Shareholding (held by whom) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mr. | VICHAI | VANADURONGWAN | M | 1,939 | 643 · Description: Thailand | Y | Chairman of the board | Executive | Existing director | 1993-12-17T00:00 | Y | Y | N | Doctoral degree | Medicine | 134 · Description: Health Care Services · 163 · Description: Leadership | 1730 · Year: 2011 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2003 · Description: Director Certification Program (DCP) · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business · 2023 · Description: Preventive Medicine Course, Preventive Medicine Association of Thailand · 2023 · Description: Training in Preventive Medicine (Public Health), Preventive Medicine Association of Thailand · 2022 · Description: Advanced Master of Management Program, AMM | Y | Y | Y | 12 | 12 | 1 | 1 | 234,000 | 200,000 | 434,000 | 66,000 | 0 | 5,111,808 | 0.84 | 4,097,732 | 0.67 | |||
| Mrs. | SAISUNEE | VANADURONGWAN | F | 1,946 | 643 · Description: Thailand | Y | Vice Chairman | Executive | Continuing director (Full term of directorship and being re-appointed as a director) | 1993-12-17T00:00 | Y | Y | N | Bachelor's degree | Medicine | 134 · Description: Health Care Services · 163 · Description: Leadership · 164 · Description: Strategic Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration | 1731 · Year: 2008 · Description: Director Certification Program (DCP) · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business · 2024 · Description: Medical for All Course for Senior Executives (PPS) · 2023 · Description: Training in Preventive Medicine (Public Health), Preventive Medicine Association of Thailand · 2023 · Description: Preventive Medicine Course, Preventive Medicine Association of Thailand · 2022 · Description: CEO Club 2022: Health Tech Investment – Opportunities for Creating a New S-Curve · 2021 · Description: Cost System Development for Management in Modern Hospitals · 2021 · Description: Chelation Therapy Training (Class 2), Thai Chelation Medical Association and the Department of Thai Traditional and Alternative Medicine Development, Ministry of Public Health · 2016 · Description: CEO CLUB 2559: CEO Branding & CEO as a Brand Champion for Sustainability | Y | N | Y | 12 | 12 | 1 | 1 | 195,000 | 150,000 | 345,000 | 79,500 | 0 | 4,097,732 | 0.67 | 5,111,808 | 0.84 | Assoc. Prof. Dr. Nop Wichai Vandurongvan (Spouse) | ||
| Mr. | MONGKON | WANITPHAKDEEDECHA | M | 1,971 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 2005-04-28T00:00 | Y | Y | N | Master's degree | Science | 134 · Description: Health Care Services · 1683 · Description: Business Administration · 163 · Description: Leadership | 1731 · Year: 2008 · Description: Director Certification Program (DCP) · 3186 · Year: 2024 · Description: ESG in the Boardroom: A Practical Guide for Board (ESG) · 2012 · Description: Role of the Compensation Committee · 2014 · Description: Medical Governance Certificate for Senior Executives (Class 3), King Prajadhipok’s Institute and the Medical Council of Thailand · 2018 · Description: Executive Program in Urban Development Management (Metropolitan) · 2023 · Description: Preventive Medicine Course, Preventive Medicine Association of Thailand · 2025 · Description: Medical Hub Executive Program (MEP 2025) · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business | Y | N | Y | 12 | 11 | 1 | 1 | 120,000 | 100,000 | 220,000 | 20,000 | 0 | 4,202,780 | 0.69 | 85,807,545 | 14.1 | Mrs. Rangsima Vanitchaphakdi (spouse) | ||
| Mr. | VIRAH | MAVICHAK | M | 1,943 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2011-03-08T00:00 | N | N | N | Doctoral degree | Engineering | 159 · Description: Engineering · 167 · Description: Internal Control · 143 · Description: Accounting · 1683 · Description: Business Administration · 163 · Description: Leadership | 1731 · Year: 2003 · Description: Director Certification Program (DCP) · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business · 1736 · Year: 2007 · Description: Role of the Chairman Program (RCP) · 2005 · Description: Audit Committee Program · 2005 · Description: Finance for Non-Finance Directors | Y | N | Y | 12 | 12 | 1 | 1 | 156,000 | 100,000 | 256,000 | 0 | 0 | 0 | 0 | 0 | 0 | None | |
| Ms. | VILAWAN | VANADURONGVAN | F | 1,947 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 2012-06-15T00:00 | N | Y | N | Bachelor's degree | Accounting | 143 · Description: Accounting · 165 · Description: Risk Management · 1683 · Description: Business Administration · 144 · Description: Finance | 1730 · Year: 2010 · Description: Director Accreditation Program (DAP) · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business · 2015 · Description: Risk Management Committee Program | Y | Y | N | 12 | 12 | 1 | 1 | 130,000 | 100,000 | 230,000 | 18,000 | 0 | 0 | 0 | 0 | 0 | None | ||
| Mr. | TINNAWAT | MAHATHARADOL | M | 1,958 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Continuing director (Full term of directorship and being re-appointed as a director) | 2014-10-17T00:00 | N | N | N | Master's degree | Business Administration | 119 · Description: Finance & Securities · 144 · Description: Finance · 143 · Description: Accounting · 118 · Description: Banking · 1683 · Description: Business Administration | 1731 · Year: 2014 · Description: Director Certification Program (DCP) · 2015 · Description: Risk Management Committee Program · 2022 · Description: Certificate of Pacific Rim Banker Program: · 1728 · Year: 2025 · Description: Board Nomination and Compensation Program (BNCP) · 2025 · Description: Director Forum 2025 - Future-Ready Boards: Board Nomination and Compensation Strategies by IOD · 2025 · Description: Online Director’s Briefing 4/2025 – ESG Risks Mitigation by IOD · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business | Y | N | Y | 12 | 11 | 1 | 1 | 144,000 | 100,000 | 244,000 | 0 | 0 | 0 | 0 | 0 | 0 | None | |
| Ms. | NOPPORN | TIRAWATTANAGOOL | F | 1,954 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Continuing director (Full term of directorship and being re-appointed as a director) | 2014-10-17T00:00 | N | N | N | Bachelor's degree | Accounting | 143 · Description: Accounting · 119 · Description: Finance & Securities · 144 · Description: Finance · 118 · Description: Banking · 1683 · Description: Business Administration | 1730 · Year: 2003 · Description: Director Accreditation Program (DAP) · 2008 · Description: Role of the Compensation Committee · 2010 · Description: Audit Committee Program · 1731 · Year: 2010 · Description: Director Certification Program (DCP) · 1735 · Year: 2015 · Description: Risk Management Program for Corporate Leaders (RCL) · 2011 · Description: Financial Institutions Governance Program (FGP) 2/2554, IOD · 1738 · Year: 2024 · Description: Subsidiary Governance Program (SGP) · 2013 · Description: Anti-Corruption for Executive Program (ACEP) 7/2556, IOD · 2017 · Description: National Director Conference 2017 “Steering Governance in a Changing World” , IOD · 2018 · Description: National Director Conference 2018 “Rising above Disruption: A Call for Action”,OD · 2021 · Description: Leadership Behind Closed Door 2021, IOD · 2022 · Description: BOT Digital Finance Conference 2022 · 2022 · Description: Thought Leadership Session – Sustainable and Climate Finance 2022 · 2023 · Description: Global trend of climate change and Net Zero journey 2023 · 2023 · Description: People Management Trend 2023 · 2023 · Description: Climate Governance 2/2023, IOD · 2024 · Description: Office Market Update and Office Style Trend 2024 · 2024 · Description: Subsidiary Governance Program (SGP) , IOD · 2024 · Description: Director Forum 2024 "Holistic Health Trends for Directors : Maximizing Performance through Mind-Body Wellness", IOD · 2024 · Description: Allianz Briefing 2024 · 2025 · Description: Business Transformation and Leadership Summit 2025 Symphony of Disruptions -The Great Convergence, IOD · 2025 · Description: Overall Economic Outlook & Market Update in Retail, Residence, Office and Hotel Business 2025 · 2025 · Description: ESG Risk Mitigation: What Directors Need to Know Before Risks Become Organizational Turning Points (2025) · 2025 · Description: Econ and Market Outlook Update Retail, Hotel & Tourist, Residential Property, Mall & Office Property sector Outlook Update 2025 · 2025 · Description: Board Cyber Forum 2025: Cyber Defense with AI and Innovation Strategies · 2025 · Description: Thailand Real Estate Industry Outlook 2025 · 2025 · Description: The Importance and Roles of Directors in Enterprise Risk Management (2025) · 2025 · Description: ESG Insights-Impact on the Real Estate Industry 2025 · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business | Y | Y | Y | 12 | 12 | 1 | 1 | 156,000 | 100,000 | 256,000 | 0 | 0 | 0 | 0 | 0 | 0 | None | |
| Mr. | PORNTEP | SIRIWANARANGSUN | M | 1,955 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Continuing director (Full term of directorship and being re-appointed as a director) | 2016-02-19T00:00 | N | N | N | Doctoral degree | Finance | 134 · Description: Health Care Services · 144 · Description: Finance · 166 · Description: Audit · 143 · Description: Accounting · 147 · Description: Sustainability | 1731 · Year: 2015 · Description: Director Certification Program (DCP) · 1734 · Year: 2015 · Description: Financial Statements for Directors (FSD) · 1735 · Year: 2019 · Description: Risk Management Program for Corporate Leaders (RCL) | Y | N | Y | 12 | 12 | 1 | 1 | 156,000 | 100,000 | 256,000 | 0 | 0 | 0 | 0 | 0 | 0 | None | |
| Mr. | PRUT | ROJMAHAMONGKOL | M | 1,970 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 2016-04-22T00:00 | N | Y | N | Master's degree | Science | 150 · Description: IT Management · 160 · Description: Architecture · 143 · Description: Accounting · 148 · Description: Procurement · 1683 · Description: Business Administration | 1731 · Year: 2010 · Description: Director Certification Program (DCP) · 1734 · Year: 2010 · Description: Financial Statements for Directors (FSD) · 2018 · Description: Executive Program in Urban Management · 2019 · Description: Certificate Program in Medical Governance for Senior Executives · 2025 · Description: Digital Medical Executive Program (Class 1, 2025), Mahidol Adulyadej Foundation Institute · 2025 · Description: Wellness Business and Beyond (WBB Class 3), Preventive Medicine Association of Thailand · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business | Y | N | Y | 12 | 12 | 1 | 1 | 130,000 | 100,000 | 230,000 | 23,000 | 0 | 4,210,000 | 0.69 | 85,807,546 | 14.1 | Mrs. Pat Rojanamahamongkol (spouse) | ||
| Mr. | BAVORNRAT | VANADURONGWAN | M | 1,976 | 643 · Description: Thailand | Y | Director | Non-executive | N | Existing director | 2023-04-16T00:00 | Y | Y | N | Bachelor's degree | Medicine | 1683 · Description: Business Administration · 134 · Description: Health Care Services · 144 · Description: Finance · 147 · Description: Sustainability | 1730 · Year: 2023 · Description: Director Accreditation Program (DAP) · 2023 · Description: Basic Preventive Medicine Program · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business | Y | Y | N | 12 | 10 | 1 | 1 | 132,000 | 100,000 | 232,000 | 18,000 | 0 | 98,307,961 | 16.15 | 496,666 | 0.08 | Teerawan Vandurongvan (spouse) | |
| Mr. | JESSADA CHOR | CHAROENYING | M | 1,965 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2024-06-11T00:00 | N | N | N | Doctoral degree | other | Finance and Accounting | 143 · Description: Accounting · 144 · Description: Finance · 166 · Description: Audit | 1730 · Year: 2024 · Description: Director Accreditation Program (DAP) · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business | Y | Y | N | 12 | 12 | 1 | 1 | 156,000 | 0 | 156,000 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Mr. | APICHAI | NIMGIRAWATH | M | 1,976 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2024-11-12T00:00 | N | N | N | Bachelor's degree | Engineering | 140 · Description: Information & Communication Technology · 142 · Description: Marketing · 150 · Description: IT Management · 159 · Description: Engineering · 166 · Description: Audit | 1731 · Year: 2018 · Description: Director Certification Program (DCP) · 2025 · Description: Army War College Program, Class 70 (AWC 70), National Defence Studies Institute, Thailand · 2025 · Description: National Defence College Program, Class 68 (NDC 68), National Defence College of Thailand · 2025 · Description: Politics and Governance Course in a Democratic System for Senior Executives, Higher Diploma, No. 27 by College of Politics and Governance King Prajadhipok's Institute · 2025 · Description: Proactive Risk Management for Sustainable Healthcare Business · 2024 · Description: The Advanced Insurance Academy · 2020 · Description: Capital Market Academy #31 (CMA-31) | Y | N | Y | 12 | 11 | 1 | 1 | 144,000 | 0 | 144,000 | 0 |
Board Meetings & Remuneration
Date of the Annual General Meeting
2025-04-21T00:00
Was an Extraordinary General Meeting Held?
No
Board Meeting Allowance (Baht)
1853000.0
Other Board Remuneration (Baht)
1150000.0
Total Board Remuneration (Baht)
3003000.0
Balance of Power Between the Board and Management
Are There Measures Balancing the Board's and Management's Power?
Yes
Measures Balancing the Board's and Management's Power
The Chairman of the Board and the Chief Executive Officer shall oversee and approve the determination of the meeting agenda, with the participation of at least one Independent Director in the consideration and determination of the agenda for meetings of the Board of Directors.
Methods Used to Balance Power
| Method |
|---|
| Appointment of an independent director Participate in determining the meeting agenda for the committee |
Board Roles, Duties and Charter
Does the Company Have a Board Charter?
Yes
Content of the Board Charter
The Board of Directors, as representatives of shareholders, plays an important role in determining the business direction of Srivichai Vejvivat Public Company Limited (the "Company") and supervising the Company's management to comply with the law, objectives and regulations in order to create value for the business and for the best benefit of the Company and shareholders in the long term. This Board of Directors Charter aims to define the scope of work, powers, duties and responsibilities, as well as the operational guidelines and operations of the Board of Directors.
Composition of the Board of Directors
include :
• Chairman of the Board of Directors
• Executive Director
• Non executive directors
• Independent directors
The main components are as follows:
1) The number of the board of directors shall be as determined by the shareholders’ meeting, taking into account the appropriate number for the size of the company’s business and the efficient operation of the company. When combined, the number shall not be less than 5 persons.
2) The board of directors shall consist of at least half of the total number of directors who must reside in the Kingdom.
3) The board of directors need not be shareholders of the company.
4) Shareholders shall consider and approve the appointment of the company’s directors.
5) The board of directors shall consist of independent directors who are truly independent from the management and have no business relationship or other relationship that may influence the independent exercise of discretion, totaling not less than one-third of the total number of directors, but not less than 3 persons.
6) The board of directors shall elect one director to be the chairman of the board of directors. In the event that the board of directors deems appropriate, one or more directors may be elected as the vice chairman of the board of directors. The vice chairman shall have duties according to the company’s regulations, which are assigned by the chairman of the board of directors.
7) The CEO shall be appointed as a director of the board of directors by position, and shall not be the same person as the chairman of the board of directors.
8) The board of directors shall appoint an appropriate person as the company secretary. In the event that the board of directors deems appropriate, an assistant company secretary may be appointed to be responsible for preparing the board of directors’ meetings, overseeing the activities of the board of directors, and coordinating the reporting to shareholders. Stock Exchange of Thailand and other relevant agencies (if any). The Company Secretary and Assistant Company Secretary have the duty to attend the Board of Directors' meetings but have no right to vote in any case.
Qualifications of the Board of Directors
The Board of Directors is comprised of qualified persons in various fields who have expertise, experience, leadership and vision. The important qualifications are as follows:
1) Being a person with knowledge, capability, honesty, integrity, ethics in business operations and having sufficient time to devote knowledge, capability and perform duties for the company.
2) Having qualifications and not having prohibited characteristics according to the Public Limited Company Act, the Securities and Exchange Act and other related laws, including not having characteristics indicating a lack of suitability to be trusted to manage a business with public shareholders as announced by the Securities and Exchange Commission (“SEC”).
3) The Company’s directors can hold directorship positions in other companies, but such directorship must not be an obstacle to the performance of duties as a director of the Company and must comply with the guidelines of the SEC and the Stock Exchange of Thailand (“Stock Exchange”).
4) Not being a person who is engaged in a business of the same nature and in competition with the Company’s business, or becoming a partner in a general partnership or a partner with unlimited liability in a limited partnership, or being a director of another company engaged in a business of the same nature and in competition with the Company’s business, whether for personal benefit or for the benefit of others. Unless notified to the shareholders' meeting before the resolution is made for appointment
5) Independent directors must have qualifications regarding independence as determined by the Company and in accordance with the guidelines announced by the Capital Market Supervisory Board and must be a person who can look after the interests of all shareholders equally and does not create conflicts of interest. In addition, they must be able to attend meetings of the Board of Directors and express opinions independently. The Company has determined that independent directors must have the following qualifications:
(5.1) Holding shares not exceeding one percent of the total number of voting shares of the Company, its parent company, subsidiary company, affiliated company, major shareholder or controlling person of the Company, including shares held by related persons of such independent director;
(5.2) Not being or having been a director who participates in the management of the Company, employee, staff, salaried advisor or controlling person of the Company, its parent company, subsidiary company, affiliated company, same-level subsidiary company, major shareholder or controlling person of the Company, unless such characteristics have been removed for at least two years prior to appointment; such prohibited characteristics do not include cases where the independent director used to be a civil servant or advisor to a government agency which is a major shareholder or controlling person of the Company ;
(5.3) Not being a person who is related by blood or by legal registration as a father, mother, spouse, sibling and child, including spouse of a child of another director, executive, major shareholder, controlling person or a person to be nominated as a director, executive or controlling person of the Company or its subsidiary.
(5.4) Not having or having had a business relationship with the Company, its parent company, subsidiary company, affiliated company, major shareholder or controlling person of the Company in a manner that may obstruct the exercise of independent judgment, and not being or having been a significant shareholder or controlling person of a person who has a business relationship with the Company, its parent company, subsidiary company, affiliated company, major shareholder;
(5.5) Not being or having been an auditor of the Company, its parent company, subsidiary company, affiliated company, major shareholder or controlling person of the Company, and not being a significant shareholder, controlling person or partner of an audit office in which an auditor of the Company, its parent company, subsidiary company, affiliated company, major shareholder or controlling person of the Company is affiliated, unless not being of such a nature for at least two years prior to appointment;
(5.6) Not being or having been a provider of any professional services, including providing legal advisory services or financial advisory services who receives a service fee of more than two million baht per year from the Company, its parent company, subsidiary company, affiliated company, major shareholder or controlling person of the Company, and not being a significant shareholder, controlling person or partner of such professional services provider, unless not being of such a nature for at least two years prior to appointment;
(5.7) Not being a director appointed as a representative of the Company’s directors, major shareholders or shareholders who are related to a major shareholder.
(5.8) is not a person who is engaged in a business of the same nature and in significant competition with the business of the Company or its subsidiaries, or is a significant partner in a partnership, or is a director who participates in the management, an employee, a staff member, a consultant who receives a regular salary, or holds more than one percent of the total number of shares with voting rights of another company which is engaged in a business of the same nature and in significant competition with the business of the Company or its subsidiaries;
(5.9) does not have any other characteristics which make it impossible to express independent opinions regarding the operations of the Company.
Appointment and term of office
The term of office of the Company’s directors shall be determined in accordance with the Company’s regulations, with details as follows:
1) The appointment of the Company’s directors shall be in accordance with the Company’s regulations and the provisions of relevant laws. It shall be transparent and clear. The consideration shall include the educational background and professional experience of the individual, with sufficient details for the benefit of the Board of Directors and shareholders in making decisions.
2) The Nomination and Remuneration Committee shall select and nominate individuals who possess all the qualifications specified in this charter to serve as Company directors. The names of such individuals shall be submitted to the Board of Directors’ meeting for consideration of appointment or to the shareholders’ meeting for consideration of appointment (as the case may be). In the event that the Board of Directors has not yet appointed the Nomination and Remuneration Committee, or in the event that there is no Nomination and Remuneration Committee, or in the event that there is a Nomination and Remuneration Committee but is unable to perform its duties due to insufficient quorum or inability to vote due to conflicts of interest, the Board of Directors shall perform such duties in the first paragraph on behalf of the Nomination and Remuneration Committee.
3) In the event that a director is appointed to replace a vacant director position for reasons other than retirement by rotation, the Nomination and Remuneration Committee shall select a person who possesses all the qualifications specified in this charter and is not prohibited by law to nominate such person to the Board of Directors’ meeting. To appoint a director to replace him/her at the next meeting of the board of directors, unless the remaining term of that director is less than 2 months. In this case, a person who assumes the position of director in such case shall serve only for the remaining term of the director who has left the position. In the event that the board of directors has not yet appointed a selection and remuneration committee, or in the event that there is no selection and remuneration committee, or in the event that there is a selection and remuneration committee but cannot perform their duties due to insufficient quorum or cannot vote due to having an interest in the selection and nomination process and nominating a person who has all the qualifications according to the first paragraph, the board of directors shall perform such duties according to the first paragraph instead of the selection and remuneration committee.
4) Directors of the company shall serve for a term of 3 years, and upon completion of the term, they may be considered for appointment as directors of the company again.
5) Independent directors shall have a term of office not exceeding 9 years from the date they were first appointed as independent directors, unless the board of directors considers the necessity and reasonableness, in which case the board of directors may appoint such person to continue serving as an independent director of the company.
6) At every annual general meeting of shareholders, one-third of the total number of directors at that time shall retire from their positions. If the number of directors cannot be divided exactly into three parts, the number nearest to one-third shall retire. Directors who have vacated their positions may be re-elected to resume their positions. Directors who must retire from their positions in the first and second years after the company’s registration shall be drawn by lot. In subsequent years, the director who has been in the position the longest shall retire.
7) In addition to vacating their positions according to the aforementioned terms, directors may vacate their positions upon
(1) death;
(2) resignation;
(3) lacking the qualifications to be a company director or having prohibited characteristics under the law governing public limited companies or having characteristics indicating a lack of suitability to be trusted to manage a business with public shareholders as specified in the Securities and Exchange Act (and amendments) and relevant announcements of the Securities and Exchange Commission; and
(4) the shareholders’ meeting resolves to remove them from their positions. (With a vote of not less than three-quarters (3/4) of the number of shareholders attending the meeting and having the right to vote and with shares totaling not less than half of the number of shares held by shareholders attending the meeting and having the right to vote)
(5) the court orders the removal from the position of director of the company.
8) Any director who wishes to resign from the position must submit a resignation letter to the company. The resignation is effective from the date the resignation letter reaches the company.
Scope of power, duties and responsibilities
The Board of Directors realizes the importance of good governance in building trust among shareholders and all stakeholders. Each director shall perform his/her duties with responsibility, honesty and prudence, protect the Company’s interests, and comply with the law, objectives, regulations and resolutions of the Board of Directors and shareholders’ meetings for the utmost benefit of the Company. Therefore, the roles, duties and responsibilities of the Board of Directors are as follows:
1) Perform duties with responsibility, caution and honesty, taking into account the utmost benefit of the Company and all shareholders, and shall perform duties and supervise the Company’s affairs in accordance with the law, objectives, regulations of the Company, resolutions of the Board of Directors’ meetings and shareholders’ meetings.
2) Set and consider approving the Company’s objectives, visions, strategies, business directions, goals, guidelines, policies, business plans, budgets, management structures, and approval authority as proposed by the Board of Directors, and monitor and supervise the management and follow up on the Company’s executives’ performance to ensure that they are in accordance with the objectives, main goals, policies, business plans and budgets set efficiently and effectively, and supervise the allocation of important resources, management and performance of the executives or any persons assigned to perform such duties for the utmost benefit of the Company, the Company and its shareholders, including reviewing strategies and business directions.
3) Continuously and consistently monitor and evaluate the performance of the Executive Board and the Company's subcommittees to achieve the strategies and plans and budgets, and supervise the reporting of the Company's performance.
4) Supervise the Company to conduct business in accordance with the principles of good corporate governance, ethics, respect for the rights and responsibilities of shareholders and stakeholders, and conduct business that benefits society and the environment, including being able to adapt to changing factors.
5) Establish a succession plan to prepare for the succession of the CEO and senior executives in the event that the CEO or senior executives retire, resign, or are unable to perform their duties, so that the Company’s management can proceed continuously. The Nomination and Remuneration Committee shall oversee the preparation of the succession plan and report the results of the succession plan to the Board of Directors at least once a year. The Committee shall also supervise the management and development of personnel to ensure that they have the appropriate number, knowledge, skills, experience, and motivation. In the event that the Board of Directors has not yet appointed a Nomination and Remuneration Committee, or in the event that there is no Nomination and Remuneration Committee, or in the event that there is a Nomination and Remuneration Committee but is unable to perform its duties due to insufficient quorum or inability to vote due to vested interests in the selection process and nominating persons who are fully qualified according to the first paragraph, the Board of Directors shall perform such duties according to the first paragraph instead of the Nomination and Remuneration Committee.
6) Consider and approve the appointment of persons who have the qualifications and do not have the prohibited characteristics specified in the Public Limited Companies Act B.E. 2535 and the Securities and Exchange Act, including related announcements, regulations, and/or rules to hold the position of directors of the Company. In the event of appointing a director to replace a director position that is vacant for reasons other than the expiration of the term.
7) Consider appointing the Audit Committee with qualifications as specified in the Audit Committee Charter and the Securities and Exchange Act, the Capital Market Supervisory Board’s announcement, including the announcements, regulations and/or rules of the Stock Exchange of Thailand.
8) Consider appointing the Executive Committee by selecting from the Company’s directors and/or executives and/or external persons with qualifications as specified in the Executive Committee Charter, and specifying the scope, powers, duties and responsibilities of the Executive Committee.
9) Consider appointing other subcommittees and specifying the scope, powers and responsibilities to assist and support the Board of Directors’ performance of duties as appropriate.
10) Consider appointing the Chief Executive Officer with necessary and appropriate knowledge and experience, and specifying the scope, powers and responsibilities, and setting the framework and policy for salary determination, salary adjustment, bonus determination, compensation and rewards for the Chief Executive Officer.
11) Consider appointing the Company Secretary with necessary and appropriate knowledge and experience, and specifying the scope, powers, duties and responsibilities to assist the Board of Directors in performing various tasks so that the Company’s operations comply with relevant laws, announcements and regulations.
12) Consider specifying and amending the names of directors authorized to sign and bind the Company.
13) Consider appointing individuals to serve as directors or executives of subsidiaries. Or an affiliated company in an amount not less than the proportion of shareholding in the subsidiary or affiliated company and having clearly defined the scope, powers, duties and responsibilities of the appointed directors and executives, including specifying a clear framework of authority to exercise discretion in voting at the board of directors’ meeting of the subsidiary or affiliated company on important matters that must be approved by the board of directors in advance in order to control the management to be in accordance with the company’s policy and to conduct various transactions in accordance with the law, including disclosing financial information, operating results, related transactions and the acquisition or disposal of significant assets completely and correctly.
14) Consider, approve and express opinions on the acquisition or disposal of assets, except that such transactions require approval from the shareholders’ meeting. Such consideration and approval shall be in accordance with the law, announcements and/or related regulations.
15) Consider, approve and express opinions on related transactions, except that such transactions require approval from the shareholders’ meeting. Such consideration and approval shall be in accordance with the law, announcements and/or related regulations.
16) Consider and approve the payment of interim dividends to shareholders and report such dividend payment to the shareholders’ meeting at the next shareholders’ meeting.
17) Prepare annual reports and be responsible for preparing and disclosing consolidated financial statements, including the Company’s specific financial statements as of the end of the Company’s accounting period, which have been audited by the auditors to be accurate and reflect the financial position and operating results of the past year, in accordance with the generally accepted accounting standards, in order to present them to the shareholders’ meeting for consideration and approval.
18) Consider selecting and approving the proposed list of the Company’s auditors, including considering and determining appropriate remuneration, as proposed by the Audit Committee, before presenting them to the shareholders’ meeting at the annual general meeting for consideration and approval.
19) Ensure that the Company has an appropriate and efficient accounting system, and arrange for a system for preparing financial reports and disclosing important information correctly, adequately, on time, in accordance with relevant rules, standards, and practices, including monitoring and overseeing the adequacy of the Company’s financial liquidity and debt repayment capability.
20) Consider and determine the risk management policy covering the entire organization, and supervise the establishment of a system or process for risk management and internal control that is adequate, appropriate, and effective, with supporting measures and control methods to appropriately reduce the impact on the Company’s business.
21) Acknowledge the audit report of the Audit Committee and other subcommittees of the Company.
22) Supervise the establishment of appropriate policy framework and compensation structure that motivates executives and employees at all levels to perform their duties in accordance with the organization’s main objectives and goals and in accordance with the long-term benefits of the Company, including considering the appropriateness of the proportion of compensation in the form of salary and compensation in relation to the short-term and long-term performance of the Company, and determining the compensation payment policy.
23) Establish a written policy on good corporate governance and anti-corruption policy in accordance with the principles of good governance, at least in accordance with the guidelines set by the Stock Exchange of Thailand and/or the SEC Office, and effectively apply such policies to ensure that the Company is responsible to all relevant groups with fairness, by arranging communication at all levels of the organization and to outsiders to ensure practical implementation.
24) Oversee and manage conflicts of interest that may arise among the Company’s stakeholders, including preventing the improper use of the Company’s assets, information and opportunities, and conducting transactions with persons related to the Company in an inappropriate manner. In the event that any director has a stake in any transaction with the Company or has an increase or decrease in the Company’s shareholding.
25) Ensure that the roles and duties of the Board of Directors and subcommittees, the number of meetings and the number of meetings attended by each director in the past year, and report the performance of all subcommittees.
26) Promote the Company ’s directors and executives to attend various seminars organized by the Thai Institute of Directors Association in courses related to the duties and responsibilities of directors and executives.
27) Follow up and supervise the Company’s management and operations to ensure that they comply with the Company’s policies, laws related to business operations, including the Securities and Exchange Act, the Capital Market Supervisory Board’s announcements, and the regulations of the Stock Exchange of Thailand, as applicable, to the extent that they do not conflict with or contradict other laws.
28) Organize an annual general meeting of shareholders within 4 months from the end of the Company’s fiscal year, and conduct the shareholders’ meeting in a smooth, transparent, and efficient manner, including ensuring that the resolutions of the meeting and the preparation of the shareholders’ meeting report are disclosed accurately and completely.
29) Seek professional opinions from external organizations if necessary to support appropriate decision-making.
30) Consider and approve matters with fair consideration of the benefits of shareholders and all groups of stakeholders of the Company.
31) Assign or appoint one or more directors or any other person to perform any act on behalf of the Board of Directors within the time as the Board of Directors deems appropriate. The Board of Directors may revoke, revoke, change or amend such authority. However, the assignment of authority, duties and responsibilities of the Board of Directors shall not be in the nature of authorization or sub-authorization that allows the Board of Directors or the authorized person of the Board of Directors to approve any transaction in which they or any person who may have a conflict of interest (as defined in the announcement of the Securities and Exchange Commission or the announcement of the Capital Market Supervisory Board) may have an interest or may receive any benefit in any form or may have any other conflict of interest with the Company, except for the approval of transactions in accordance with the policies and criteria considered and approved by the shareholders' meeting or the Board of Directors.
Board of Directors’ Meetings
The Board of Directors’ Meetings and Shareholders’ Meetings are scheduled, including the preparation of financial statements, communication and disclosure of the Company’s information to relevant parties in an adequate and appropriate manner, as follows:
1) At least 6 meetings shall be scheduled per year, with meeting dates set in advance throughout the year and additional special meetings may be held as necessary.
2) The Chairman of the Board of Directors and the Chief Executive Officer shall oversee and approve the meeting agenda, with one independent director participating in the consideration and determination of the Board of Directors’ meeting agenda.
3) In calling a Board of Directors’ meeting, the Chairman of the Board of Directors or an assigned person shall send a meeting invitation letter, along with the agenda and supporting documents to all directors at least 7 days in advance of the meeting date, to allow directors sufficient time to study the information. However, in urgent cases to protect the rights or benefits of the Company, the meeting invitation may be announced by other methods or the meeting date may be set earlier.
4) The Chairman of the Board of Directors shall act as the meeting chairman and shall be responsible for allocating sufficient time for each agenda item for directors to independently discuss and express their opinions on important issues.
5) Directors who have a vested interest in any matter shall not have the right to vote on that matter. Directors with such interests can attend the meeting during the consideration of such matters to allow the meeting to ask for details directly from the directors with such interests. However, the directors with such interests must leave the meeting when voting.
6) Organize an extraordinary shareholders' meeting to consider urgent matters, which are matters that the law requires approval from the shareholders' meeting before proceeding, such as capital increase, capital reduction, issuance of debentures, sale or transfer of all or some important parts of the company's business to another person, or purchase or transfer of the business of another company to the company, and amendment of the memorandum of association or the company's regulations, etc.
Quorum and Voting
1) In a meeting of the Board of Directors, no less than half of the total number of directors must be present to constitute a quorum. In the event that the Chairman of the Board of Directors is not present at the meeting or is unable to perform his/her duties, the Vice Chairman of the Board of Directors shall be the Chairman. Or, if the Vice Chairman of the Board of Directors is unable to perform his/her duties, the directors attending the meeting shall elect one of the directors to be the Chairman of the meeting.
2) Voting shall be by majority vote, and if any director opposes the resolution, the objection shall be recorded in the meeting minutes.
3) In casting votes, each director has the right to cast one vote, except that a director who has a vested interest in any matter shall not have the right to vote on that matter. In the event of a tie, the Chairman of the meeting shall cast one additional vote as the deciding vote.
Remuneration
of the Board of Directors
The Board of Directors receives remuneration as approved by the shareholders’ meeting. The remuneration consideration process must be transparent, appropriate for the duties and responsibilities, and at a level comparable to those practiced in the same industry.
Performance Evaluation of the Board of Directors
The performance evaluation of the Board of Directors shall be held annually, evaluating the performance of the entire Board of Directors and individual directors, in order to improve the Board’s performance for greater efficiency, in accordance with the Good Corporate Governance Guidelines: Self-evaluation of Listed Companies’ Boards.
Other Board Governance Matters
Board Governance Practices
| Practice | Yes / No |
|---|---|
| The chairman of the board and the highest-ranking executive are from the same person | N |
| The chairman of the board is an independent director | N |
| The chairman of the board and the highest-ranking executive are from the same family | Y |
| Chairman is a member of the executive board or taskforce | N |
| The company appoints at least one independent director to determine the agenda of the board of directors’ meeting | Y |
Subcommittees — Overview
Subcommittees — Introduction
The Board of Directors has appointed various subcommittees, including the Audit Committee, the Nomination and Remuneration Committee, the Risk Management Committee, the Financial and Investment Planning Working Group, and the Corporate Governance and Sustainability Committee to scrutinize and oversee the Company's operations in specific areas and to comply with the rules and regulations of the Securities and Exchange Commission and the Stock Exchange of Thailand. This ensures that the Board of Directors' duties are carried out with maximum efficiency and effectiveness.
Audit Committee
Audit Committee — Introduction
The Audit Committee comprises not fewer than three independent directors who possess the qualifications in accordance with the criteria prescribed in the notifications of the Securities and Exchange Commission and are appointed by the Board of Directors. As of 31 December 2025, the Audit Committee consists of a total of three members, as follows:
Audit Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee |
|---|---|
1. Financial Reporting and Information Disclosure
(1) Review and consider the Company's financial reports to ensure they are complete, accurate, reliable, timely, and contain adequate disclosures.
(2) Consider, select, and propose the appointment of independent auditors to serve as the Company's auditors, propose their remuneration, and propose the termination of auditors during their term.
2. Internal Control
Review to ensure that the Company has an adequate internal control system and appropriate risk management, including good corporate governance.
3. Internal Audit
(1) Review to ensure that the Company has an independent internal audit function and an effective internal audit system.
(2) Consider and propose the appointment, transfer, termination, and performance evaluation of the Head of Internal Audit.
(3) Review and provide recommendations on the charter, annual audit plan, Audit Committee meeting plan, budget, and staffing of the internal audit function.
(4) Review and consider audit findings jointly with internal auditors.
(5) Coordinate understanding between the Audit Committee, management, the internal audit function, and the Company's external auditors to ensure consistency and mutual support.
4. Compliance with Laws and Regulations
(1) Review and monitor the Company's compliance with securities and exchange laws, regulations of the Stock Exchange of Thailand, and other laws relevant to the Company's business to prevent damage, including penalties, warnings, and damage to the Company's reputation.
(2) Consider connected transactions or transactions that may involve conflicts of interest to ensure that such transactions are reasonable.
(3) Oversee the anti-corruption policy to ensure that the Company complies with the established policy.
5. Reporting
(1) Prepare the Audit Committee report and disclose it in the Company's annual report, including items specified by the Stock Exchange of Thailand, and signed by the Audit Committee Chairman.
(2) Report the performance of the Audit Committee to the Board of Directors annually.
(3) In performing its duties, if the Audit Committee discovers or suspects any act or transaction that may have a material impact on the Company's financial position and operating results, the Audit Committee shall report to the Board of Directors for improvement or rectification within a timeframe deemed appropriate by the Audit Committee. Such acts or transactions include:
1) Transactions that give rise to conflicts of interest.
2) Fraud, irregularities, or material weaknesses in internal control.
3) Violations of securities and exchange laws, regulations of the Stock Exchange of Thailand, or laws related to the business.
(4) If the Board of Directors or management fails to take corrective actions on any act or transaction that may have a material impact on the Company's financial position and operating results, any Audit Committee member may report to the Securities and Exchange Commission or the Stock Exchange of Thailand.
(5) If the Company's auditor discovers any suspicious events related to directors, executives, or any person responsible for the Company's and its subsidiaries' operations that violate the law, and the auditor has reported such events to the Audit Committee, the Audit Committee must promptly conduct further investigations and have the responsible officer report the preliminary investigation results to the Securities and Exchange Commission and the auditor within 30 days from the date of receiving the report from the auditor.
6. Other Responsibilities
(1) Review and update the Audit Committee Charter and submit it to the Board of Directors for approval annually.
(2) Provide advice on good corporate governance, including assessment and reporting on compliance with the Corporate Governance Code.
(3) Have the authority to investigate relevant individuals and matters within the scope of its duties and responsibilities.
(4) The Audit Committee may seek advice from independent external consultants when necessary, with the Company bearing the expenses.
(5) Conduct a self-assessment of its performance and responsibilities at least once a year and present it to the Board of Directors for acknowledgement.
(6) Monitor and evaluate the effectiveness of service delivery, customer satisfaction, and value for money to ensure quality in accordance with established goals.
(7) Perform other duties as assigned by the Board of Directors. | 3091 · Description: Audit of financial statements and internal controls |
Audit Committee Members
| Title | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Has Accounting or Financial Expertise? | Skills & Expertise | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mr. | JESSADA CHOR | CHAROENYING | Chairman of the audit committee | M | 1,965 | 643 · Description: Thailand | Y | 2024-07-09T00:00 | Doctoral degree | other | Finance and Accounting | Y | 143 · Description: Accounting · 144 · Description: Finance · 166 · Description: Audit | 12 | 12 | 180,000 | 0 | 180,000 | 0 | 0 |
| Mr. | PORNTEP | SIRIWANARANGSUN | Audit committee | M | 1,955 | 643 · Description: Thailand | Y | 2016-02-19T00:00 | Doctoral degree | Finance | Y | 134 · Description: Health Care Services · 144 · Description: Finance · 166 · Description: Audit · 143 · Description: Accounting · 147 · Description: Sustainability | 12 | 12 | 144,000 | 0 | 144,000 | 0 | 0 | |
| Mr. | APICHAI | NIMGIRAWATH | Audit committee | M | 1,976 | 643 · Description: Thailand | Y | 2024-11-12T00:00 | Bachelor's degree | Engineering | N | 140 · Description: Information & Communication Technology · 142 · Description: Marketing · 150 · Description: IT Management · 159 · Description: Engineering · 166 · Description: Audit | 12 | 12 | 144,000 | 0 | 144,000 | 0 |
Audit Committee — Meeting Allowance (Baht)
468000.0
Audit Committee — Other Remuneration (Baht)
0.0
Audit Committee — Total Remuneration (Baht)
468000.0
Executive Committee
Executive Committee — Introduction
The Executive Committee comprises individuals deemed appropriate by the Board of Directors to be appointed to oversee and manage the Company’s operations, with a minimum of five members. Members of the Executive Committee are not required to be directors, executives, or employees of the Company. As of 31 December 2025, the Executive Committee consists of a total of 14 members, as follows:
Executive Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee |
|---|---|
1) Formulate the company's vision, strategies, business direction, goals, approaches, policies, business plans, budgets, management structure, and authority limits for the Board of Directors' approval. Implement the approved plans and monitor their performance to ensure efficiency and effectiveness.
2) Oversee the company's general administration through the Chief Executive Officer.
3) Review and consider proposals from the management regarding investment policies, business expansion, public relations, financial planning, annual reports, budgets (including annual budgets), human resource management, and IT investment for further consideration and decision by the Board of Directors.
4) Have the authority to appoint working groups for the company's operations or management. Define the authority, duties, and responsibilities of these working groups, and supervise them to ensure their operations align with the company's policies and objectives.
5) Monitor the company's performance to ensure alignment with the policies and objectives approved by the Board of Directors. Supervise the operations to ensure quality and efficiency.
6) Review the annual budget proposed by the management before submitting it to the Board of Directors for consideration and approval.
7) Explore the feasibility of new investment projects. Have the authority to consider and approve the company's investment or joint investment with individuals, juristic persons, or other business organizations. This includes participating in bids, undertaking projects as deemed appropriate by the Board of Directors, and executing related legal transactions until completion, in accordance with the Authority Limits, as determined by the Board of Directors, relevant laws and regulations, and the company's regulations.
8) Approve significant capital expenditures specified in the annual budget, according to the Authority Limits, as assigned by the Board of Directors, or as previously approved in principle by the Board of Directors.
9) Approve contracts and transactions related to the company's ordinary course of business (e.g., sales, service provision, investment or joint ventures for the company's normal operations, and transactions that benefit the company's objectives) within the limits specified in the Authority Limits table approved by the Board of Directors, as determined by the Board of Directors, and including exceeding the budget limits as per the financial authority.
10) Consider and approve financial transactions with banks or financial institutions to support the company's ordinary course of business. This includes opening and closing bank accounts, borrowing, obtaining credit lines, pledging, mortgaging, guaranteeing, and buying, selling, or registering land ownership for the company's operations. This also includes executing related legal transactions until completion, in accordance with the Authority Limits table approved by the Board of Directors, as determined by the Board of Directors, relevant laws and regulations, and the company's regulations. If the amount exceeds the budget approved by the Board of Directors, it must be presented to the Board for approval at the next meeting. If the company's assets are used as collateral, approval from the Board of Directors is required.
11) Review and monitor the company's operational results. Propose interim or annual dividend payments for the Board of Directors' approval.
12) Define the organizational structure, management authority, and the framework and policies for appointment, hiring, transfer, termination, compensation structure, salary determination, bonuses, and rewards as specified in the human resource management authority table approved by the Board of Directors.
13) Consider and approve the appointment of advisors or advisory committees necessary for the company's operations as appropriate. Determine the remuneration, allowances, welfare, facilities, and other expenses for the chairman, advisors, or advisory committees within the annual budget approved by the Board of Directors.
14) Review and propose to the Board of Directors any necessary revisions to the scope of authority, duties, and responsibilities of the Executive Committee to align with the current circumstances.
15) Perform other duties as assigned by the Board of Directors or according to the policies set by the Board of Directors.
16) Delegate authority to one or more persons to act on behalf of the Executive Committee. However, the delegation of authority, duties, and responsibilities of the Executive Committee shall not constitute a delegation or sub-delegation that enables the Executive Committee or its delegate to approve matters in which they or related persons (as defined in the notifications of the Securities and Exchange Commission or the Capital Market Supervisory Board) may have interests, may benefit in any way, or may have other conflicts of interest with the company. Exceptions are made for approvals that comply with the policies and criteria previously approved by the Board of Directors. | 3097 · Other name: Establish policies and strategies and manage the company's operations in accordance with the policies. · Description: Others |
Executive Committee Members
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mrs. | SAISUNEE | VANADURONGWAN | Chairman of the executive committee | F | 1,946 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Bachelor's degree | Medicine | 18 | 18 | 0 | 0 | 0 | 79,500 | 0 | ||
| Mr. | MONGKON | WANITPHAKDEEDECHA | Vice-chairman of the executive committee | M | 1,971 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Master's degree | Science | 18 | 14 | 0 | 0 | 0 | 20,000 | 0 | ||
| Mr. | PRUT | ROJMAHAMONGKOL | Vice-chairman of the executive committee | M | 1,970 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Master's degree | Science | 18 | 17 | 0 | 0 | 0 | 23,000 | 0 | ||
| Mrs. | TEERAWAN | VANADURONGVAN | Vice-chairman of the executive committee | F | 1,983 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Doctoral degree | other | Transdermal Vaccine Delivery Technology | 18 | 18 | 0 | 0 | 0 | 12,000 | 0 | |
| Mr. | Sakda | Tangchitwatanakorn | Member of the executive committee | M | 1,956 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Doctoral degree | other | Political Science | 18 | 17 | 0 | 80,000 | 80,000 | 25,000 | 0 | |
| other | Flt.Lt. | KORN | TALTHIP | Member of the executive committee | M | 1,979 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Doctoral degree | Economics | 18 | 18 | 0 | 0 | 0 | 0 | 0 | |
| other | Dr. | Saranatra | Wai | Member of the executive committee | F | 1,952 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Bachelor's degree | other | Medical Science | 18 | 9 | 0 | 0 | 0 | 8,000 | 0 |
| other | Dr. | SUNEE | TEERAKAROONWONG | Member of the executive committee | F | 1,948 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Bachelor's degree | Medicine | 18 | 17 | 0 | 0 | 0 | 12,000 | 0 | |
| Ms. | KHWANYUEN | SUKSOMPOT | Member of the executive committee | F | 1,971 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Master's degree | Business Administration | 18 | 17 | 0 | 0 | 0 | 0 | 0 | ||
| Mrs. | Phannee | Kannee | Member of the executive committee | F | 1,965 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Master's degree | other | Public Administration | 18 | 17 | 0 | 0 | 0 | 0 | 0 | |
| other | Pol. Lt. | VACHARAC | CHUAPAKNAM | Member of the executive committee | M | 1,963 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Bachelor's degree | Medicine | 18 | 16 | 0 | 0 | 0 | 0 | 0 | |
| Mrs. | SUNEE | JOYCHUMRAS | Member of the executive committee | F | 1,960 | 643 · Description: Thailand | Y | 2024-08-01T00:00 | Master's degree | other | Political Science | 18 | 18 | 0 | 0 | 0 | 0 | 0 | |
| Ms. | Ratcharin | Boonrueng | Member of the executive committee | F | 1,980 | 643 · Description: Thailand | Y | 2025-01-07T00:00 | Bachelor's degree | Accounting | 18 | 18 | 0 | 0 | 0 | 0 | 0 | ||
| Mr. | Surachai | Kaewhiran | Member of the executive committee | M | 1,964 | 643 · Description: Thailand | Y | 2025-01-07T00:00 | Bachelor's degree | Medicine | 18 | 17 | 0 | 0 | 0 | 0 | 0 |
Executive Committee — Meeting Allowance (Baht)
0.0
Executive Committee — Other Remuneration (Baht)
80000.0
Executive Committee — Total Remuneration (Baht)
80000.0
Other Subcommittees
Other Subcommittees
| Subcommittee Name | Type of Subcommittee | Roles, Duties and Responsibilities | Meetings Held | Subcommittee Remuneration | Members |
|---|---|---|---|---|---|
| Nomination and Remuneration Committee | 3093 · Description: Director and executive nomination · 3094 · Description: Remuneration | **Nomination**
1) Establish policies, criteria, and procedures for the nomination of the Company's Board of Directors, sub-committees, and Chief Executive Officer, taking into consideration the appropriate number, structure, and composition of the Board, as well as determining the qualifications of directors in accordance with the size, type, and complexity of the business, to be proposed to the Board of Directors and/or submitted for approval by the shareholders' meeting, as the case may be.
2) Consider, recruit, and nominate qualified individuals with appropriate knowledge, experience, and expertise to serve as members of the Board of Directors, sub-committees, and Chief Executive Officer by submitting their names to the Board of Directors for appointment and/or presenting them to the shareholders' meeting for further appointment consideration (as the case may be), including reviewing the background of such individuals to ensure that they meet the qualifications stipulated in the Company's Articles of Association and relevant laws, and that they do not conflict with or contradict laws related to the Company's business operations. The Nomination and Remuneration Committee will ensure that shareholders receive sufficient information about the nominated individuals to make informed decisions.
3) Oversee the development of a succession plan to prepare for the succession of the Chief Executive Officer and senior management in the event of retirement, resignation, or incapacitation, to ensure the continuity of the Company's operations. The Nomination and Remuneration Committee will report on the progress of the succession plan to the Board of Directors on a regular basis, at least once a year. The committee will also ensure that there are sufficient human resources with appropriate knowledge, skills, experience, and motivation.
4) Review the criteria and procedures for the nomination of directors to be presented to the Board of Directors prior to the nomination of directors whose terms are expiring.
5) Consider the independence of each independent director to ensure that the Company's independent directors are fully qualified.
6) In the event that the Nomination and Remuneration Committee nominates a director whose term has expired to return to office, the Nomination and Remuneration Committee will consider the performance of such director and should present the performance, contributions, and attendance records at Board and shareholder meetings for the shareholders' consideration.
7) Consider the appropriateness of knowledge, experience, and specific expertise that would be beneficial to the Company, with experience in the core business or industry in which the Company operates, to ensure that the Board of Directors has the required composition. A Board skill matrix will be developed to help align the recruitment of directors with the Company's business direction.
8) Consider the format and develop a plan for the development of the Board of Directors, sub-committees, and Chief Executive Officer to enhance the knowledge of both current and new personnel to understand the Company's business, roles and responsibilities, and key developments such as economic and industry conditions, rules, and regulations related to the Company's business.
9) Perform other duties as assigned by the Board of Directors with the approval of the Nomination and Remuneration Committee.
**Remuneration**
1) Consider and establish policies and criteria for determining the remuneration and other benefits, such as meeting attendance fees (whether in cash, securities, or otherwise), of the Board of Directors, sub-committees, and Chief Executive Officer, including salary adjustments for the Chief Executive Officer, to be proposed to the Board of Directors and/or the shareholders' meeting for consideration and approval, as the case may be. The remuneration of directors should be comparable to the level prevailing in the industry, and the remuneration of the Chief Executive Officer should be aligned with the Company's objectives and goals and in the best interests of the Company in the long term.
2) Establish policies and criteria for evaluating the performance of the Board of Directors, sub-committees, and Chief Executive Officer to determine annual remuneration and submit them to the Board of Directors for approval.
3) Disclose the policies and criteria for determining remuneration and other benefits and prepare a report on such remuneration in the Company's annual report.
4) Perform other duties as assigned by the Board of Directors with the approval of the Nomination and Remuneration Committee.
5) The Nomination and Remuneration Committee is responsible for reviewing and proposing to the Board of Directors for amendment the scope of authority, duties, and responsibilities of the Nomination and Remuneration Committee to be in line with the circumstances. | 2 | 57000.0 · Meeting allowance: 57000.0 · Other remuneration: 0.0 | 260 · Last name: MAVICHAK · Position: 37 · First name: VIRAH · Total meeting: 2 · Meeting allowance: 15000.0 · Other remuneration: 0.0 · Total remuneration: 15000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 262 · Last name: VANADURONGWAN · Position: 39 · First name: SAISUNEE · Total meeting: 2 · Meeting allowance: 10000.0 · Other remuneration: 0.0 · Total remuneration: 10000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 79500.0 · 260 · Last name: WANITPHAKDEEDECHA · Position: 39 · First name: MONGKON · Total meeting: 2 · Meeting allowance: 10000.0 · Other remuneration: 0.0 · Total remuneration: 10000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 20000.0 · 261 · Last name: VANADURONGVAN · Position: 39 · First name: VILAWAN · Total meeting: 2 · Meeting allowance: 10000.0 · Other remuneration: 0.0 · Total remuneration: 10000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 18000.0 · 260 · Last name: CHAROENYING · Position: 39 · First name: JESSADA CHOR · Total meeting: 2 · Meeting allowance: 12000.0 · Other remuneration: 0.0 · Total remuneration: 12000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 |
| Corporate Governance and Sustainability Committee | 3096 · Description: Sustainability development · 3097 · Other name: Promote the disclosure of corporate governance and sustainable business development information to reflect true value and worth. · Description: Others · 3097 · Other name: Promote, support, and enhance good corporate governance standards and sustainable business development. · Description: Others | The Corporate Governance and Sustainability Committee is responsible for establishing and overseeing the process of driving the business towards sustainability at the organizational level. To ensure that the implementation of policies, strategies, and business operations of the Hospital Group integrates the framework and materiality of sustainability with a clear path towards sustainable development, personnel at all levels, from the Board of Directors and management to employees, are involved in leading the business to achieve its goals. This assures stakeholders that the Vichaiyut Hospital Group operates based on the principles of GRC (Governance, Risk, and Compliance), maintaining its competitive edge and developing its potential for growth, even amidst the changing business environment.
1. Corporate Governance
1) Establish policies and practices regarding corporate governance and business ethics for the Vichaiyut Hospital Group to comply with relevant laws, regulations, and criteria, as well as best practices of leading organizations both domestically and internationally.
2) Oversee the operations of the Vichaiyut Hospital Group to ensure they align with the principles of good corporate governance of regulatory bodies such as the Securities and Exchange Commission, ensuring compliance with established policies and practices.
3) Oversee the effectiveness and appropriateness of measures related to the prevention of fraud, corruption, and bribery within the context of the Vichaiyut Hospital Group. Encourage management, including the Board of Directors, executives, and employees at all levels, to acknowledge, prioritize, and strictly adhere to these measures.
4) Supervise compliance with regulations, including policies, procedures, whistleblowing channels, and complaint response mechanisms, to ensure effectiveness. Review reports on significant compliance issues.
5) Oversee the communication and dissemination of good corporate governance culture and business ethics to ensure understanding and compliance among the Board of Directors, executives, and employees at all levels.
6) Review good corporate governance and business ethics practices in comparison to international standards and recommendations from various assessments. Present findings to the Board of Directors for approval to continuously develop and enhance the corporate governance standards of the Vichaiyut Hospital Group.
7) Consider and approve the performance evaluation form for the Board of Directors. Approve the evaluation results for submission to the Board of Directors for consideration and implementation to enhance the effectiveness of the Board's functions.
8) Consider approaches and plans for Board training and development.
2. Driving Business Towards Sustainability
1) Oversee and advise on the Sustainability Management framework to align with international standards. Review and adjust the Vichaiyut Hospital Group's operational approaches in response to changing circumstances and environmental factors, including:
(1) Consider and establish a sustainability philosophy and policy, along with operational strategies to achieve business goals and outcomes in the economic, environmental, social, and governance dimensions of the Vichaiyut Hospital Group.
(2) Consider the establishment of a Sustainability Development Management (SDM) team to share responsibility and execute tasks, seeking approval from the Board of Directors.
(3) Consider and define material sustainability issues. Provide recommendations to the Board of Directors regarding sustainability policies that align with the good corporate governance framework of the Vichaiyut Hospital Group, seeking approval from the Board of Directors.
(4) Determine a clear timeframe for implementation and assign responsibilities for each aspect.
2) Oversee the implementation of social responsibility, environmental responsibility, and stakeholder engagement in accordance with good corporate governance principles. Provide guidance, monitor progress, and ensure effective communication channels to build trust with shareholders and all stakeholder groups, including:
(1) Ensure compliance with policies, strategies, and operational plans for sustainable development through the Sustainability Development (SD) team.
(2) Provide guidance and consider approval of the Sustainability Report for submission to the Board of Directors.
3) Human Resources Policy and Organizational Culture
(1) Provide opinions and recommendations on human resources policies to align with the business strategies of the Vichaiyut Hospital Group, including the improvement and development of personnel to possess appropriate knowledge, skills, experience, and motivation.
(2) Establish policies and oversee the development of succession plans for the positions of Chief Executive Officer, Managing Director, and other key management roles. Identify potential successors and establish a personnel development system to ensure readiness.
(3) Consider and provide opinions on plans to cultivate and develop organizational culture.
4) Possess the authority to request information from relevant departments and invite stakeholders to meetings to provide necessary information.
5) Consider the responsibilities related to good corporate governance, sustainable development, and measures to combat fraud, corruption, and bribery for all or part of the Vichaiyut Hospital Group as deemed appropriate.
6) Undertake other actions as deemed appropriate to ensure effective corporate governance and drive the Vichaiyut Hospital Group towards achieving its sustainability goals or as assigned by the Board of Directors.
7) Carry out any duties and responsibilities as stipulated by laws, announcements, regulations, or orders from government agencies and relevant regulatory bodies.
8) In performing its duties, the Corporate Governance and Sustainability Committee may seek opinions from independent professional advisors or appoint working groups as deemed necessary and appropriate. The Committee shall ensure that its members receive training and knowledge enhancement in areas related to the Committee's operations, with the Vichaiyut Hospital Group being responsible for the expenses. | 2 | 0.0 · Meeting allowance: 0.0 · Other remuneration: 0.0 | 260 · Last name: SIRIWANARANGSUN · Position: 37 · First name: PORNTEP · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 260 · Last name: VANADURONGWAN · Position: 38 · First name: BAVORNRAT · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 18000.0 · 260 · Last name: WANITPHAKDEEDECHA · Position: 39 · First name: MONGKON · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 20000.0 · 260 · Last name: ROJMAHAMONGKOL · Position: 39 · First name: PRUT · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 23000.0 · 262 · Last name: VANADURONGVAN · Position: 39 · First name: TEERAWAN · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 12000.0 |
| Working Group for Financial and Investment Planning | 3097 · Other name: Effectively manage the company's financial planning and investment. · Description: Others · 3097 · Other name: Financial and Investment Risk Management · Description: Others | 1. Establish financial and investment policies, objectives, and strategies.
2. Develop investment plans and direction.
3. Secure appropriate funding for investments.
4. Analyze and manage financial and investment risks.
5. Monitor, oversee, control, and manage cash flow to align with company objectives.
6. Perform other duties as assigned by the Board of Directors and the Company President. | 1 | 0.0 · Meeting allowance: 0.0 · Other remuneration: 0.0 | 261 · Last name: VANADURONGVAN · Position: 37 · First name: VILAWAN · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 18000.0 · 261 · Last name: TIRAWATTANAGOOL · Position: 39 · First name: NOPPORN · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 260 · Last name: MAHATHARADOL · Position: 39 · First name: TINNAWAT · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 260 · Last name: WANITPHAKDEEDECHA · Position: 39 · First name: MONGKON · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 20000.0 · 260 · Last name: ROJMAHAMONGKOL · Position: 39 · First name: PRUT · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 23000.0 · 260 · Last name: VANADURONGWAN · Position: 39 · First name: BAVORNRAT · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 18000.0 · 260 · Last name: Tangchitwatanakorn · Position: 39 · First name: Sakda · Total meeting: 1 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 25000.0 |
| Risk Management Committee | 3092 · Description: Risk management | 1. Establish and review the policy, framework for enterprise risk management, and risk governance guidelines. These should encompass various significant risks related to the company's and its subsidiaries' business operations. Additionally, define appropriate and effective risk levels and key risk indicators.
2. Oversee the establishment of an organizational structure that supports effective Risk Governance.
3. Supervise and support the implementation of enterprise risk management in alignment with business strategies, objectives, and evolving circumstances. This includes overseeing the assessment and monitoring systems to ensure that the management's risk management remains at an appropriate level and adheres to established policies. Furthermore, ensure that the risk management of operations is suitable for maintaining competitiveness, including overseeing the management's implementation of appropriate risk prevention, mitigation, and limitation measures.
4. Review risk management reports and provide insights on potential risks. This includes evaluating the management's proposed control measures or Mitigation Plans to ensure that risks are managed within acceptable levels and that the overall risk management process for the company and its subsidiaries is continuously improved.
5. Encourage and promote collaboration in the overall risk management of the company and its subsidiaries. Review the adequacy of risk management policies and ensure their continuous implementation.
6. Oversee the implementation of Mitigation Plans, review risk disclosures to regulatory bodies and general investors.
7. Perform other duties as assigned by the Board of Directors. Report to the Board on the status of risks, risk management effectiveness, significant factors and issues, and areas for improvement to align with risk management policies and strategies.
8. Promote and support the continuous improvement and development of risk management systems at all levels throughout the organization. | 2 | 15000.0 · Meeting allowance: 15000.0 · Other remuneration: 0.0 | 260 · Last name: VANADURONGWAN · Position: 37 · First name: BAVORNRAT · Total meeting: 2 · Meeting allowance: 15000.0 · Other remuneration: 0.0 · Total remuneration: 15000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 18000.0 · 262 · Last name: VANADURONGVAN · Position: 39 · First name: TEERAWAN · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 12000.0 · 262 · Last name: Kannee · Position: 39 · First name: Phannee · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 262 · Last name: JOYCHUMRAS · Position: 39 · First name: SUNEE · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 261 · Last name: Boonrueng · Position: 39 · First name: Ratcharin · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 261 · Last name: Rueanthongdi · Position: 39 · First name: Nichapa · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 |
| Subcommittee for Evaluating the Performance of the Chief Executive Officer | 3097 · Other name: Evaluation of the Chief Executive Officer's performance for use in determining compensation. · Description: Others | 1. Establish Criteria and Evaluation Methods
- Establish appropriate, transparent, and fair methods and procedures for evaluating the performance of the Chief Executive Officer.
- Utilize metrics aligned with the company's goals, strategies, and performance.
2. Conduct Performance Evaluation
- Conduct an annual performance evaluation of the Chief Executive Officer.
- Analyze the evaluation results to provide constructive feedback for the development and effectiveness of the Chief Executive Officer.
- Present the evaluation results to the Board of Directors.
3. Report Evaluation Results to the Board of Directors for Remuneration and Development Considerations
- Provide recommendations for improvement and development of the Chief Executive Officer's potential to lead the company towards its objectives.
- Review and improve the evaluation process. | 1 | 37000.0 · Meeting allowance: 37000.0 · Other remuneration: 0.0 | 260 · Last name: MAVICHAK · Position: 37 · First name: VIRAH · Total meeting: 1 · Meeting allowance: 15000.0 · Other remuneration: 0.0 · Total remuneration: 15000.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 261 · Last name: VANADURONGVAN · Position: 39 · First name: VILAWAN · Total meeting: 1 · Meeting allowance: 10000.0 · Other remuneration: 0.0 · Total remuneration: 10000.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 18000.0 · 260 · Last name: CHAROENYING · Position: 39 · First name: JESSADA CHOR · Total meeting: 1 · Meeting allowance: 12000.0 · Other remuneration: 0.0 · Total remuneration: 12000.0 · Total meeting attendance: 1 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 |
Executives
Names and Positions — Introduction
As of 31 December 2025, the Company had a total of six executives, as defined under the term “executives” pursuant to the Notification of the Capital Market Supervisory Board No. TorJor. 17/2551 (2008) regarding the Definitions in Notifications Relating to the Issuance and Offering of Securities, as follows:
(1) Asst. Prof. Saisunee Vanadurongwan, M.D. Chief Executive Officer
(2) Mongkon Wanitphakdeedecha, M.D., M.Sc. Deputy Chief Executive Officer
(3) Prut Rojmahamongkol Deputy Chief Executive Officer
(4) Teerawan Vanadurongwan, PG.Cert.,PH.D. Deputy Chief Executive Officer
(5) Flt.Lt. Korn Talthip, M.D.,Ph.D. Deputy Chief Executive Officer
(6) Dr. Sakda Tungchitwatanakorn Chief Financial Officer
Executives
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Skills & Expertise | Is the Highest-ranking Executive? | Is the Highest-ranking Accounting or Finance Officer? | Directly Responsible for Accounting? | Appointed After the End of the Fiscal Year? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mrs. | SAISUNEE | VANADURONGWAN | CHIEF EXECUTIVE OFFICER (CEO) | F | 1,946 | 643 · Description: Thailand | Y | 1993-12-17T00:00 | Bachelor's degree | Medicine | 134 · Description: Health Care Services · 163 · Description: Leadership · 164 · Description: Strategic Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration | Y | N | N | N | ||
| Mr. | MONGKON | WANITPHAKDEEDECHA | Deputy Chief Executive Officer | M | 1,971 | 643 · Description: Thailand | Y | 2011-02-22T00:00 | Master's degree | Science | 134 · Description: Health Care Services · 1683 · Description: Business Administration · 163 · Description: Leadership | N | N | N | N | ||
| Mr. | PRUT | ROJMAHAMONGKOL | Deputy Chief Executive Officer | M | 1,970 | 643 · Description: Thailand | Y | 2024-01-15T00:00 | Master's degree | Science | 150 · Description: IT Management · 160 · Description: Architecture · 143 · Description: Accounting · 148 · Description: Procurement · 1683 · Description: Business Administration | N | N | N | N | ||
| Mrs. | TEERAWAN | VANADURONGVAN | Deputy Chief Executive Officer | F | 1,983 | 643 · Description: Thailand | Y | 2024-01-15T00:00 | Doctoral degree | other | Transdermal Vaccine Delivery Technology | 134 · Description: Health Care Services · 146 · Description: Human Resource Management · 147 · Description: Sustainability · 165 · Description: Risk Management · 1683 · Description: Business Administration | N | N | N | N | |
| Mr. | Sakda | Tangchitwatanakorn | Chief Financial Officer (CFO) | M | 1,956 | 643 · Description: Thailand | Y | 2011-02-22T00:00 | Doctoral degree | other | Political Science | 143 · Description: Accounting · 144 · Description: Finance · 1683 · Description: Business Administration | N | Y | Y | N | |
| other | Flt.Lt. | KORN | TALTHIP | Deputy Chief Executive Office | M | 1,979 | 643 · Description: Thailand | Y | 2025-11-24T00:00 | Doctoral degree | Economics | 1683 · Description: Business Administration · 134 · Description: Health Care Services | N | N | N | N |
Executive Remuneration
Monetary Remuneration — Description
The Company has implemented a careful and transparent performance evaluation process for executives. The remuneration of the Chief Executive Officer and senior executives is determined appropriately and fairly based on reasonable criteria. These criteria take into account the responsibilities associated with each executive position, as well as the achievement of performance targets set for both the organization and its teams. The compensation framework reflects the success in driving business performance and achieving outcomes that maximize benefits for the Company.
In 2024, the Company provided remuneration to Five executives (as defined by the Securities and Exchange Commission). The remuneration was in the form of salaries, bonuses, provident fund contributions, and other compensation, all of which were accounted for as part of the Company’s administrative expenses. The total executive remuneration for 2025 amounted to THB 38,577,949 a figure determined based on performance evaluations and the responsibilities effectively undertaken by each executive.
Monetary Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total remuneration of executive directors and executives (baht) | 39,519,493 | 34,493,133 | 32,933,011 |
| Total remuneration of executive directors (baht) | 30,816,974 | 27,979,814 | 24,718,220 |
| Total remuneration of executives (baht) | 8,702,519 | 6,513,319 | 8,214,791 |
Other Remuneration — Description
The Company and its subsidiaries provide additional compensation in the form of non-monetary benefits, including medical care benefits and tailored business suits for executives.
Other Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Company’s contribution to provident fund for executive directors and executives (Baht) | 258,456 | 243,924 | 72,132 |
| Employee Stock Ownership Plan (ESOP) | 0 | 0 | 0 |
| Employee Joint Investment Program (EJIP) | 0 | 0 | 0 |
Remuneration or Benefits Payable to Executives
| Metric | Amount (Baht) |
|---|---|
| Outstanding remuneration or benefits of executive directors and executives in the past year (baht) | 0 |
| Estimated remuneration of executive directors and executives in the current year (baht) | 0 |
Remuneration Policy
Executive Remuneration Policy
The Company has established a remuneration policy and guidelines for executives with the objective of motivating management to effectively drive the organization toward achieving its business objectives while supporting sustainable growth. The policy is implemented under principles of fairness, transparency, and alignment with the Company’s performance in both the short and long term.
The Company conducts annual performance evaluations of the Chief Executive Officer and senior executives, with performance indicators linked to the Company’s operating results, management effectiveness, service quality, risk management, as well as sustainability and environmental, social, and governance (ESG) objectives. This approach ensures that remuneration appropriately reflects actual performance outcomes.
The remuneration structure comprises salary, performance-based bonuses, and other appropriate remuneration or benefits, including medical welfare. The determination of remuneration levels takes into account roles, duties, and responsibilities, and includes benchmarking against companies in the same industry or of comparable size, in order to attract and retain qualified and capable executives who can continuously drive the Company’s success.
This remuneration policy emphasizes a balance between short-term incentives and long-term value creation, supports transparent and well-governed business operations, and takes into consideration the interests of all stakeholders. The policy is aligned with sustainability assessment frameworks and internationally recognized standards for responsible investment.
Principles for Determining Remuneration
The Nomination and Remuneration Committee is responsible for reviewing and determining the remuneration and other benefits of the Board of Directors, sub-committees, and the Chief Executive Officer. Remuneration is determined in accordance with the following key principles:
Alignment of remuneration with the Company’s performance and the performance of directors and executives;
Consideration of both financial performance indicators and sustainability-related factors, such as corporate governance, risk management, quality of medical services, and responsibilities toward stakeholders;
Balancing short-term incentives with long-term value creation to support stable and sustainable growth; and
Consideration of directors’ duties, responsibilities, commitment, and the value contributed through their performance, as well as the need to attract directors with appropriate qualifications in line with the Company’s requirements.
Remuneration and other benefits of the Board of Directors and sub-committees are proposed to the Board of Directors for consideration within the approved framework and subsequently submitted for approval by the shareholders’ meeting.
Remuneration Structure
The remuneration of directors and executives comprises the following components:
Monthly remuneration:
The Company provides monthly remuneration to non-executive directors in the form of fixed remuneration, paid on a regular monthly basis regardless of the number of Board meetings held.Other benefits:
Other monetary and non-monetary benefits may include meeting allowances for the Board of Directors, sub-committees, and the Chief Executive Officer, as well as salary adjustments for the Chief Executive Officer, which are proposed for consideration and approval by the Board of Directors and/or the shareholders’ meeting, as applicable.
Director remuneration is determined at a level that is comparable to prevailing practices within the industry and is aligned with the Company’s objectives and long-term interests. Remuneration may be set as a fixed amount or based on specific criteria, and may be determined on a periodic basis or remain effective until amended by a resolution of the shareholders’ meeting.
Oversight and Review
The Company regularly reviews its remuneration policy and remuneration levels at least once a year to ensure alignment with business performance, the operating environment, and ESG trends. Directors or executives with a vested interest are excluded from deliberations on their own remuneration.
This remuneration policy enables the Company to attract and retain personnel with appropriate knowledge, capabilities, and experience, supports efficient and transparent business operations, and promotes sustainable long-term economic returns.
Was an Opinion Obtained from the Board and the Remuneration Committee?
Yes
Opinion of the Board and the Remuneration Committee
For the consideration of executive compensation, the Company has established a fair and transparent remuneration process. This process is based on criteria developed from the performance evaluation of executives at each level. The assessment takes into account the Company's overall performance, as well as the individual contributions of executives across various aspects, ensuring a thorough and comprehensive evaluation. The compensation determination is directly linked to achieving tangible results that reflect operational efficiency and the successful attainment of the Company's business objectives. This approach fosters motivation among executives at all levels to continuously enhance their performance for the overall benefit of the organization.
Employees
Employees — Sub-section Introduction
As of December 31, 2025 the Company and its subsidiaries had a total of 1,898 employees (excluding the directors and executives of the Company and its subsidiaries), categorized as follows:
Categorized | Totals |
Doctors | 92 |
Nurse and Nurse assistance | 565 |
Medical Operation and support staff | 335 |
General staff | 906 |
In accordance with the Company's practices, physicians are engaged under contractual arrangements that do not constitute permanent employee status. Accordingly, excluding physicians, the Company and its subsidiaries had a total of 1,806 employees, with details classified by functional areas as follows:
Significant Changes in Headcount — Introduction
For the fiscal year ended 31 December 2025, Srivichaivejvivat Public Company Limited did not experience any significant changes in the number of employees. The Company manages its workforce in an efficient and systematic manner, with due consideration to maintaining an appropriate organizational structure that aligns with its business strategy and sustainable growth objectives. In addition, the Company places emphasis on fostering a stable working environment, continuously developing employee capabilities, and effectively managing human resource-related costs. These practices reflect the Company’s commitment to good corporate governance principles and its responsibility toward stakeholders.
Any Significant Change in Headcount in the Past 3 Years?
No
Provident Fund
Does the Company Have a Provident Fund?
Yes
Provident Fund Policy
The Company and its subsidiaries have a provident fund management policy that focuses on providing employees with long-term financial security and promoting savings for their future. The Company will contribute to the fund on the same day that members make contributions, at a rate of 2% of the employee's monthly salary. In the event that a member's membership is terminated, the member is entitled to receive the employer's contribution and the benefits of the employer's contribution according to the number of years of membership.
Provident Fund Arrangements — Introduction
The Company, its subsidiaries, and employees have jointly established a provident fund since February 1, 2007, with MFC Asset Management Public Company Limited. The objective is to build morale and provide incentives for employees and to encourage them to work with the Company and its subsidiaries in the long term. The Company and its subsidiaries have changed the provident fund manager from MFC Asset Management Public Company Limited to AIA (Thailand) Public Company Limited. The Company has signed an agreement appointing AIA Masterpool Provident Fund, which is registered, to manage the provident fund of the Company and its subsidiaries from October 1, 2011, until the present.
The Company has appointed a registered provident fund to manage the fund’s assets, giving due consideration to suitability, transparency, and the protection of members’ best interests. The Company emphasizes the selection of fund managers that integrate responsible investment principles into their investment processes, including consideration of environmental, social, and governance (ESG) factors, and that operate in alignment with recognized standards of good corporate governance and stewardship.
Does the Fund Committee Follow the I Code?
Yes
Contribution Method and Rate
The Company has set the employee contribution rate and the employer contribution rate to the provident fund at 2% of the employee’s monthly salary. In the event that a member’s membership is terminated, the employee is entitled to receive his or her own contributions together with all accrued benefits, as well as the employer’s contributions and related benefits in accordance with the length of membership.
This approach reflects the Company’s commitment to promoting long-term financial security for employees in a fair and sustainable manner, as well as designing employee benefits that are linked to length of service in order to enhance work motivation and support the retention of qualified personnel. In this regard, the Company manages the provident fund under principles of good corporate governance, transparency, and the protection of members’ best interests.
Policy for Employees Not in the Provident Fund
Automatic Enrolment
No
Automatic Enrolment — Details
The Company places strong emphasis on enhancing the long-term financial security of its employees by establishing policies and practices to promote savings through the Provident Fund (PVD) for employees who have successfully completed their probation period and have been appointed as permanent employees. In this regard, the Company has implemented an automatic enrollment system for the Provident Fund to facilitate participation and encourage continuous savings from the commencement of permanent employment.
This policy reflects the Company’s commitment to providing fair and comprehensive employee welfare, reducing long-term financial security risks, and strengthening employee engagement with the organization. These efforts are supported by systematic, transparent, and well-governed fund management practices, which are aligned with the principles of good corporate governance.
Encouraging Retirement Saving
No
Encouraging Retirement Saving — Details
The Company places importance on enhancing knowledge and understanding of retirement savings among employees who have successfully completed their probation period and have been appointed as permanent employees. The Company provides continuous education on the Provident Fund (PVD) to support employees in planning their savings and making informed decisions on appropriate saving options based on their life stage and risk tolerance.
In addition, the Company clearly communicates and provides employees with comprehensive information regarding the benefits of participating in the Provident Fund, including employees’ own contributions, employer contributions, applicable tax benefits, as well as the terms and guidelines for long-term fund management. This enables employees to make well-informed and transparent decisions regarding their participation in the Provident Fund.
Providing Investment Information
No
Other Measures
No
Auditors and Audit Fees
How Audit Fees Are Reported
TOTAL
Company Auditor and Fees
| Audit Firm | Address | Sub-district | District | Province | Postcode | Fax | Auditors | Audit Fee (Baht) | Any Non-audit Fee? | Type of Non-audit Service | Non-audit Service Details | Non-audit Fee (Baht) | Amount Payable in Future (Baht) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EY OFFICE LIMITED | NO. 1875 ONE BANGKOK TOWER 3, LEVEL 34 - 37, RAMA 4 ROAD, | LUMPHINI | PATHUM WAN | Bangkok | 10330 | +66 2264 0789-90 | Manee.Rattanabunnakit@th.ey.com · Title: 261 · Regis no: 5313 · Last name: RATTANABUNNAKIT · First name: MANEE · Telephone: 022640777 · Vorapoj.Amnauypanit@th.ey.com · Title: 260 · Regis no: 4640 · Last name: ANNAUYPANIT · First name: VORAPOJ · Telephone: 022640777 · Termphong.Opanaphan@th.ey.com · Title: 260 · Regis no: 4501 · Last name: OPANAPHAN · First name: TERMPHONG · Telephone: 022640777 | 3,550,000 | Y | - Agreed-upon procedures service | - To provide agreed-upon procedures in accordance with Thai Standards on Related Services (TSRS) 4400,"Engagements to Perform Agreed-upon Procedures Regarding Financial Information" related to destruction of the inventory as conducted by Client and issue a witness report.
| 60,000 | 60,000 |
Company Secretary and Other Assigned Persons
Company Secretary — Introduction
The Board of Directors has appointed Chalanthorn Trakulweerasak as the Company Secretary, effective January 9, 2024, in accordance with Section 89/15 of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008).The Company Secretary is responsible for providing guidance to the Board of Directors and executives regarding relevant laws and regulations, ensuring that the Board's operations comply with established standards. Key responsibilities include organizing Board and shareholder meetings, recording meeting minutes, and monitoring the implementation of resolutions passed in these meetings.Additionally, the Company Secretary is in charge of preparing and maintaining essential corporate documents, such as the register of directors, meeting notices, minutes of Board and shareholder meetings, the 56-1 One Report, and records of directors' and executives' interests. Further details on the Company Secretary can be found in Attachment 1.
Company Secretary
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Chalunthorn | Trakulveerasak | cs.vichaivej@gmail.com | 024417899 ต่อ 1707 |
Chief Accountant — Introduction
The company has assigned Dr. Sakda Tangjitwattanakorn, Chief Financial Officer, as the highest-ranking executive responsible for accounting and finance. Additionally, Ms. Nichapa Ruentongdee has been appointed to oversee financial accounting. Details regarding the highest-ranking executive in accounting and finance, as well as the financial accounting supervisor, are provided in Attachment 1.
Chief Accountant
| Title | Title — Please Specify | First Name | Last Name | Telephone | |
|---|---|---|---|---|---|
| other | Ph.D. | Sakda | Tangchitwatanakorn | sakda@vichaivej.com | 024417899 ต่อ 4409 |
| Ms. | Nichapa | Ruanthongdee | numooyruan@hotmail.com | 024417899 ต่อ 4411 |
Head of Internal Audit — Introduction
The Company appointed Mr. Chinnaphat Upaijit to serve as the Head of the Internal Audit Unit of the Company, effective from 1 August 2016, with the approval of the Audit Committee.
In 2025, Mr. Chinphat Oopaijit resigned from the position of Head of the Internal Audit Unit, effective from 28 February 2025. Subsequently, the Company appointed Miss Naree Phetdam as the Head of the Internal Audit Unit, effective from 1 August 2025. Such appointment was approved by the Audit Committee, as Miss Naree Phetdam possesses appropriate qualifications, knowledge, capabilities, and experience suitable for the performance of internal audit duties. The Audit Committee therefore considered her to be adequately qualified to effectively perform such duties. Details of the Head of the Internal Audit Unit are provided in Appendix 3.
The consideration and approval of the appointment, removal, or transfer of the Head of the Internal Audit Unit of the Company shall be subject to the approval of the Audit Committee, in order to ensure that the Company’s oversight and governance are conducted in accordance with the principles of good corporate governance.
Head of Internal Audit
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Naree | Phetdam | audit.vih@gmail.com | 024417899 ต่อ 4526 |
Investor Relations Contact
Investor Relations — Introduction
The Company has assigned the Company Secretary and the Chief Financial Officer to act as representatives for investor relations, serving as key intermediaries in communicating information between the Company and its shareholders, investors, analysts, and the general public. The Office of the Company Secretary is the primary unit responsible for disclosing information and disseminating news about the Company’s activities through various channels, such as the Company’s website, Opportunity Day events, and other appropriate platforms, including Line Official.
Additionally, the Company prepares the Management Discussion and Analysis (MD&A) to ensure that the public has clear access to and a better understanding of the Company’s performance. All disclosures must be accurate, complete, and truthful and must be carried out with due diligence and caution to maintain the integrity and reliability of the information. To safeguard the Company’s reputation and business operations, unauthorized individuals or those not assigned specific responsibilities are strictly prohibited from providing company-related information, making public statements, or giving interviews to the media or the public in any manner that may impact the Company’s reputation and business operations.For further information, investors may contact the Office of the Company Secretary at Phone: +66 2441 7899 ext. 1707, 1708 , Email: shares@vichaivej.com / bod@vichaivej.com
Does the Company Have an Investor Relations Contact?
No
Representatives in Thailand (Foreign Companies)
Does the Company Have Representatives in Thailand?
No

